NASHUA, N.H., July 27, 2016 (GLOBE NEWSWIRE) -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and six months ended June 30, 2016.

Hospitals nationwide are wasting time and money on unnecessary hormone receptor tests for breast cancer patients, according to the results of a Johns Hopkins study.

Citing 3D imaging as an example of a high-cost medical technology with unclear benefits to patients, the authors of a review article posted August 8 in the Harvard Business Review make the case that gee-whiz advances have passed their peak as means of achieving optimal safety and efficacy.

Reflecting a national trend, freestanding emergency departments are sprouting in the Lone Star State, where there are now more than 200. 

In some of the more remote counties in the Badger State, telemedicine—including teleradiology—enables small hospitals to serve up modern medicine for rural residents close to where they live. 

A Florida primary-care physician who gave up the red tape of reimbursement for the hands-on of monthly retainer payments directly from patients—and for a single, discounted contract with a radiology practice—has gotten her story told in the local newspaper.

By the time 2016 is in the books, RSNA’s Research & Education Foundation will have supported 101 young researchers in 54 academic medical institutions to the tune of $4 million in grants. 

Last Thursday, CMS proposed changes in the Medicare Physician Fee Schedule (MPFS). The American College of Radiology quickly said it would be reviewing the details in the coming weeks and—in advance of that activity as well as of the September 6 comment deadline—noted its overall approval of the proposed rule as released.